$HIPO

Wall Street Analysts See a 26.6% Upside in Hippo Holdings (HIPO): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Hippo Holdings (HIPO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Aug 11, 2025, 1:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wall Street Analysts See a 26.6% Upside in Hippo Holdings (HIPO): Can the Stock Really Move This High? — source image
Decision brief

The 30-second read

$HIPOBullishMed
01

Why it matters

The positive analyst sentiment suggests potential upward price movement, but investors should remain cautious due to the medium confidence level and possible overreliance on analyst projections.

02

Market read

The news is relevant for investors interested in the insurance technology sector and those seeking growth opportunities in mid-cap stocks.

03

What to watch

Potential market volatility, macroeconomic uncertainties, or company-specific risks such as management changes or competitive pressures could negate the projected gains.

Timing: Moderate; the news is recent and relevant for the upcoming trading sessions.

Background

Hippo Holdings operates in the property insurance technology sector, with recent positive earnings estimate revisions and analyst price targets indicating investor optimism.

Company-level read

Ticker impact

$HIPOBullishMedium confidence
Context

Primary focus of the article, high relevance for trading decisions.

Expected impact

Potential upward movement of approximately 26.6% in HIPO stock price over the medium term, contingent on earnings revisions and market sentiment.

Evidence & confidence

The upside projection is derived from analyst price targets and earnings revisions, which are generally reliable indicators but can be subject to market volatility and unforeseen company-specific factors.

Market effects

The insurance and property technology sectors may experience positive sentiment due to HIPO's potential growth.

Limited regional impact; primarily relevant to investors focused on the U.S. market.

Low; HIPO's market cap and international exposure are limited, making this news less relevant on a global scale.

Counterpoint

The projected upside may be overly optimistic; analyst targets can be biased or overly optimistic, and earnings revisions might not materialize as expected.

Key entities

  • Hippo Holdings

    A provider of property insurance technology solutions.

Related articles

$HIPOHighAI 9/10

Hippo (HIPO) Q2 2026 Earnings Call Transcript

Hippo (HIPO) reported Q2 2026 results from its earnings call. Net income was $10M, up nearly 8x year over year, and adjusted net income was $21M, up 24%. Gross written premium rose 61% to $482M. The combined ratio improved to 95.8%. Hippo raised its 2028 gross written premium target to over $2.5B and adjusted net income to over $140M.

$HIPOHighAI 9/10

Hippo posts fifth straight profitable quarter, raises full-year guidance

Hippo Holdings, the technology-native insurance platform, reported net income of $10 million for the quarter ended June 30, 2026, up from $1 million in the same period last year, as the company posted its fifth consecutive quarter of profitability on both a stated and adjusted basis. Growth accelerates alongside improved underwriting Gross written premium rose 61.5% year over year to $482 million, while adjusted net income increased 23.5% to $21 million, or $0.79 per diluted share.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.